Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pexastimogene Devacirepvec
Metastatic Melanoma
Lee's Pharmaceutical Limited
P1/2
CCC
(48)
Pidnarulex
Colorectal Cancer
National Cancer Institute (NCI)
P1/2
CCC
(48)
Pimurutamab
Colon Adenocarcinoma
Shanghai Henlius Biotech
P1/2
CCC
(48)
Pirfenidone
Colorectal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
P1/2
CCC
(48)
Placental Cd117 Stem Cells
Multiple Sclerosis
Wake Forest University Health Sciences
P1/2
CCC
(48)
pm1032
Neoplasm
Biotheus Inc.
P1/2
CCC
(48)
Polo-Like Kinase 1 Inhibitor Nms-1286937
Inflammatory Breast Carcinoma
Antonio Giordano, MD
P1/2
CCC
(48)
Polo-Like Kinase 1 Inhibitor Nms-1286937
Breast Carcinoma
Antonio Giordano, MD
P1/2
CCC
(48)
Ponatinib
Leukemia, Myeloid, Accelerated-Phase
Incyte Biosciences International Sàrl
P1/2
CCC
(48)
pp65 rna lp
Malignant Glioma
University of Florida
P1/2
CCC
(48)
pp65 rna lp
Osteosarcoma
University of Florida
P1/2
CCC
(48)
pp65/tumor mrna rna-lp
Malignant Glioma
University of Florida
P1/2
CCC
(48)
pp65/tumor mrna rna-lp
Osteosarcoma
University of Florida
P1/2
CCC
(48)
Pralatrexate
Enteropathy-Associated T-Cell Lymphoma
City of Hope Medical Center
P1/2
CCC
(48)
Pralatrexate
Follicular Lymphoma
City of Hope Medical Center
P1/2
CCC
(48)
Pralatrexate
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical Center
P1/2
CCC
(48)
Pralatrexate
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
City of Hope Medical Center
P1/2
CCC
(48)
Pralatrexate
Subcutaneous Panniculitis-Like T-Cell Lymphoma
City of Hope Medical Center
P1/2
CCC
(48)
Prednisolone
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Prednisone
Gaucher Disease Type II
Prevail Therapeutics
P1/2
CCC
(48)
Prednisone
EZB-MYC+ Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P1/2
CCC
(48)
Prednisone
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Prgn-2009
Oropharyngeal Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Prgn-2009
Reproductive System Cancer
National Cancer Institute (NCI)
P1/2
CCC
(48)
Primepro™/ Primemsk™
Cardiovascular Disorder
Thomas Advanced Medical LLC
P1/2
CCC
(48)
Showing 1676 to 1700 of 6,308 assets
Previous
Page 68 of 253
Next